Ketogenic diet follow-up study in Shanghai
Part of Blood & lymphatic clinical trials.
This study follows up with people who completed the first Zhongshan Ketogenic Diet Study in 2025. It looks at the long-term effects of the diet. You may be eligible if you live in Shanghai and took part in the earlier study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in Shanghai.
- You completed the Zhongshan Ketogenic Diet Study 1 in 2025.
- You do not take anti-platelet drugs (like aspirin or clopidogrel).
- You do not have diabetes, high blood pressure, heart disease, or other metabolic conditions.
- You do not have a history of head injury, cancer, liver or kidney disease, or other serious illnesses.
- You are not pregnant, planning to become pregnant, or breastfeeding.
- You do not have bulimia, PTSD, chronic anxiety, depression, or other major mental health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the link between heart, kidney, and metabolic health in adults living in Shanghai. It follows people who were part of an earlier health study to see how their health changes over time.
This study follows pregnant women with different types of diabetes or at high risk for it. The goal is to understand how blood sugar changes during and after pregnancy and to improve care.
This trial tests an investigational medicine (SHR-1918) added to your current statin therapy to see if it helps lower your LDL ('bad') cholesterol and triglycerides more than a placebo. It may be an option if you're on a statin but still have high cholesterol.
This study looks at why a ketogenic diet can raise cholesterol. You'll follow a controlled keto diet for two weeks, and researchers will measure how your body processes fats.
This trial tests how a ketone drink affects the brain in healthy middle-aged adults. It may help researchers understand if ketones can support brain function.
This study tests a new medication called selatogrel in people with chronic coronary syndrome (long-term heart disease caused by narrowed heart arteries). Researchers want to see how the body processes this drug and whether it helps prevent future heart problems.
Hear when a new Platelet Function and Thrombus Formation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.